Search Results

41 - 50 of 110 items :

  • "acute lymphoblastic leukaemia" x
Clear All
Original article. Efficacy of intravenous dexamethasone for the prevention of vomiting associated with intrathecal chemotherapy and ketamine sedation in children: a randomized, double-blinded, crossover, placebocontrolled trial

References 1. Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009; 23:655-74. 2. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation N Engl J Med. 2009; 360:2730-41. 3. Holdsworth MT, Raisch DW, Winter SS, Chavez CM. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer. 1998; 6:132-8. 4. Langston

Open access
Preliminary Results of Introducing the Method Multiparameter Flow Cytometry in Patients with Acute Leukemia in the Republic of Macedonia

Med. 1985;103: 620-625. PMID:3862359 Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias: report of the workshop held in Leuven, Belgium, April 22-23, 1985. First MIC Cooperative Study Group. Cancer Genet Cytogenet. 1986;23:189-197. doi:10.1016/0165-4608(86)90178-0 PMID:3490303 Harris NL, Jaffe ES, Diebold J, Flandrin G, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory

Open access
Problems of high-dose methotrexatein oncological patients

, Tsalic M, Haim N. Actual body weight for determining doses of chemotherapy in obese cancer patients. Med Oncol 2003; 20: 363-367. Jaehde U, Kloft C. Dosis-Individualisierung in der Krebs-Chemotherapie. Pharm Unserer Zeit 2006; 2: 150-156. Skaerby T, Joensson P, Hjorth L, Behrentz M, Bjoerk O, Forestier E et al. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL

Open access
Advances of studies on blood diseases and bone marrow microvessel

: Evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 2004;104:1159-65. 4. Norén-Nyström U, Heyman M, Frisk P, Golovleva I, Sundström C, Porwit A, et al. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome. Br J Haematol 2009;146:521-30. 5. Antic D, Jovanovic MP, Fekete MD, Cokic V. Assessment of bone marrow microvessel density in chronic lymphocytic leukemia. Appl Immunohistochem Mol Morphol 2010;18:353-6. 6. Matuszewski L

Open access
Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer

-87. Leinung S, Horn LC, Backe J. [Male breast cancer: history, epidemiology, genetic and histopathology]. [German]. Zentralbl Chir 2007; 132 : 379-85. Murata H, Khattar NH, Gu L, Li GM. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 2005; 223 : 143-50. Latz D, Alfrink M, Nassar N, Beyerle C. Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation. Onkologie 2004; 27

Open access
Myelodysplastic syndrome with myelofibrosis in a 12-year-old patient – A case report

lymphoblastic leukaemia: implications for disease biology. Leuk Res. 2006;30:233-239. DOI: 10.1016/j.leukres.2005.06.011 4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;1145(5):937-51. DOI: 10.1182/blood-2009-03-209262 5. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-30. DOI: 10.1200/JCO.2004

Open access
The Relationship between Anxiety and Immunity in Pediatric Oncology Patients

childhood acute lymphoblastic leukemia in India and regional variation: tertiary care center experience, systematic review, and evaluation of population-based data. Pediatr Hematol Oncol . 2013;30:557-67. 14. Silvestri V, Nerini L, Missio G, et al. Levels of anxiety and pain during chemotherapy with peripheral versus central vascular access: an experimental evaluation. J Vasc Access . 2004;5:147-153. 15. Ander M, Grönqvist H, Cernvall M, et al. Development of health-related quality of life and symptoms of anxiety and depression among persons diagnosed with

Open access
Clinical Tolerance in Large Field Radiotherapy - The Knowledge Gained Over the Last Ten Years

References Esiashvili N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH, Paulino AC. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 2009;90:242-6. Shigematsu A, Kongo T, Yamamoto S, et al. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2008

Open access
Glucocorticoid Receptor in Health and Disease

, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001; 20: 7108-16. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209

Open access
Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed February 15, 2012 22. Erculj N, Kotnik BF, Debeljak M, Jazbec J, Dolzan V. The influence of folate pathway polymorphisms on high-dose methotrexate related toxicity and survival in children with non-Hodgkin malignant lymphoma. Radiol Oncol 2013; doi:10.2478/raon-2013-0076. 2013.10.26. [Epub ahea d of print] 23. Erculj N, Kotnik BF, Debeljak M, Jazbec J, Dolzan V. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2012; 53: 1096

Open access